Target intelligence / Profile preview

RNA, U6 small nuclear 240, pseudogene (RNU6-240P)

Target
RNU6-240P
Molecular classification
Other (pseudogene of a small nuclear RNA gene; not a protein, not a receptor, enzyme, transporter, or signaling molecule)
01

Overview

RNA, U6 small nuclear 240, pseudogene (RNU6-240P) is a non-coding RNA pseudogene derived from the U6 small nuclear RNA gene family[2]. Pseudogenes, unlike their functional counterparts, are generally incapable of producing functional products due to accumulated mutations or loss of regulatory elements, and thus, they are typically transcriptionally silent or functionally inert. While U6 snRNA itself is an essential catalytic RNA involved in splicing within the spliceosome, RNU6-240P does not encode a functional RNA and has not been described as participating in any regulatory or disease-related processes[2][4]. Though some pseudogenes exhibit regulatory behaviors—either as RNA decoys or competitive endogenous RNAs—there is no evidence supporting such a role for RNU6-240P. It is not considered a druggable target, and there is no information linking it to therapeutic relevance, interacting drugs, or biomarker status[4].

Other names
RNU6-240PU6-240PRNA, U6 small nuclear RNA 240, pseudogene
02

Mechanism of action

no mechanisms of drug action described, as this is not a protein or functional RNA

03

Biological functions

no described biological function; pseudogenes typically do not produce functional products; however, some rare pseudogenes can regulate parental gene expression, but this is undocumented for RNU6-240P
04

Disease associations

no established disease association; some pseudogenes are disease-relevant, but no evidence links RNU6-240P to pathology
05

Safety considerations

no safety or therapeutic concerns; not a target in pharmacology
06

Interacting drugs

no drugs reported to interact with this pseudogene
07

Biomarkers

not established as a biomarker for any condition

Beyond the preview

Go deeper on RNA, U6 small nuclear 240, pseudogene (RNU6-240P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 240, pseudogene (RNU6-240P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call